NantKwest, Inc. (54) | Business Finance (14)

Browse by Subcategory

Recent Contracts

Purchase Agreement, by and between Athenex, Inc. and ImmunityBio, Inc. dated as of January 7, 2022 (Filed With SEC on January 12, 2022)
Promissory Note by and between the Company and Nant Capital, LLC dated as of December 17, 2021 (Filed With SEC on December 20, 2021)
Common Stock Purchase Warrant, dated June 30, 2016, issued by ImmunityBio, Inc. to NantWorks, LLC (Filed With SEC on January 19, 2021)
Assignment Agreement, dated July 31, 2017, by and between ImmunityBio, Inc. and NantOmics, LLC (Filed With SEC on January 19, 2021)
Common Stock Purchase Agreement, dated April 30, 2018, by and among ImmunityBio, Inc. and NantBio, Inc (Filed With SEC on January 19, 2021)
Underwriting Agreement, dated June 24, 2020 (Filed With SEC on June 25, 2020)
Membership Interest Purchase Agreement entered into as of September 27, 2021, by and among Nant Capital, LLC and ImmunityBio, Inc (Filed With SEC on November 12, 2021)
Promissory Note, dated February 22, 2021, issued by NantCell, Inc. (f/k/a ImmunityBio, Inc.) to Nant Capital, LLC (Filed With SEC on March 10, 2021)
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC (Filed With SEC on January 19, 2021)
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantWorks, LLC (Filed With SEC on January 19, 2021)
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantCancerStemCell, LLC (Filed With SEC on January 19, 2021)
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantMobile, LLC (Filed With SEC on January 19, 2021)
Promissory Note, dated September 30, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC (Filed With SEC on January 19, 2021)
Assignment Agreement, dated July 2, 2017, by and between NantPharma, LLC and Immunotherapy NANTibody, LLC (Filed With SEC on January 19, 2021)